Neurofibromatosis type 1 (NF1) is the most common dominantly inherited cancer predisposition syndrome with prevalence of ∼1:2,000. It is caused by mutations in NF1 gene on chromosome 17. The protein product of NF1 gene is neurofibromin, which acts as a tumor suppressor protein inhibiting Ras signaling pathway. The hallmark signs of the disorder are found on the skin, but NF1 is a multisystem disorder with increased risk for e.g., cancer, pregnancy complications, osteoporosis and learning difficulties.
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00306932607174,00302841026182,alsfakia@gmail.com
Αναζήτηση αυτού του ιστολογίου
Πληροφορίες
Ετικέτες
Παρασκευή 10 Αυγούστου 2018
Neurofibromatosis type 1 and birth size: A retrospective registry-based total population study in Finland
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Small molecule inhibitor of the Wnt pathway (SM04755) as a potential topical treatment for psoriasisBackground: Psoriasis (PSO) is an autoimmune disease causing patches of thick, inflamed, scaly skin due to excessive proliferation of skin c...
-
Clinical and animal studies show that ethanol exposure and inflammation during pregnancy cause similar behavioral disturbances in the offspr...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.